Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
9h
A closer look at OpenAI CEO Sam Altman after President Trump announces a multi-billion dollar joint venture between Altman's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback